Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor T Hansel

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Respiratory Medicine|October 16, 2004
How do we measure the effectiveness of inhaled corticosteroids in clinical studies?Trevor T Hansel
Drug News & Perspectives|October 7, 2008
Antagonists of the prostaglandin D2 receptor CRTH2Roy Pettipher, Trevor T Hansel
Lancet (London, England)|September 15, 2004
Prospects for new drugs for chronic obstructive pulmonary diseasePeter J Barnes, Trevor T Hansel
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPDTrevor T Hansel, Peter J Barnes
Clinics in Chest Medicine|February 11, 2014
New drug therapies for COPDClare L Ross, Trevor T Hansel
Lancet (London, England)|September 1, 2009
New drugs for exacerbations of chronic obstructive pulmonary diseaseTrevor T Hansel, Peter J Barnes
Nature Reviews. Drug Discovery|March 31, 2007
Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseasesRoy Pettipher, Trevor T Hansel, Richard Armer
Lancet (London, England)|February 23, 2013
Microbes and mucosal immune responses in asthmaTrevor T Hansel, Sebastian L Johnston, Peter J Openshaw
Current Opinion in Pharmacology|June 18, 2003
Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?Rachel C Tennant, Edward M Erin, Peter J Barnes, et al.
Nature Reviews. Drug Discovery|March 23, 2010
The safety and side effects of monoclonal antibodiesTrevor T Hansel, Harald Kropshofer, Thomas Singer, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Respiratory Medicine|October 16, 2004
How do we measure the effectiveness of inhaled corticosteroids in clinical studies?Trevor T Hansel
Drug News & Perspectives|October 7, 2008
Antagonists of the prostaglandin D2 receptor CRTH2Roy Pettipher, Trevor T Hansel
Lancet (London, England)|September 15, 2004
Prospects for new drugs for chronic obstructive pulmonary diseasePeter J Barnes, Trevor T Hansel
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPDTrevor T Hansel, Peter J Barnes
Clinics in Chest Medicine|February 11, 2014
New drug therapies for COPDClare L Ross, Trevor T Hansel
Lancet (London, England)|September 1, 2009
New drugs for exacerbations of chronic obstructive pulmonary diseaseTrevor T Hansel, Peter J Barnes
Nature Reviews. Drug Discovery|March 31, 2007
Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseasesRoy Pettipher, Trevor T Hansel, Richard Armer
Lancet (London, England)|February 23, 2013
Microbes and mucosal immune responses in asthmaTrevor T Hansel, Sebastian L Johnston, Peter J Openshaw
Current Opinion in Pharmacology|June 18, 2003
Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?Rachel C Tennant, Edward M Erin, Peter J Barnes, et al.
Nature Reviews. Drug Discovery|March 23, 2010
The safety and side effects of monoclonal antibodiesTrevor T Hansel, Harald Kropshofer, Thomas Singer, et al.
Pageof 6